Induction of HIV-1 replication by allogeneic stimulation

Journal of Immunology

Volumn 162, Issue 12, 1999, Pages 7543-7548

  Moriuchi, Hiroyuki ^a,b   Moriuchi, Masako ^a   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENEIC RESTRICTION; ARTICLE; BLOOD TRANSFUSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LATENT VIRUS INFECTION; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS EXPRESSION; VIRUS INDUCTION; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHEMOKINES, CC; COCULTURE TECHNIQUES; HIV-1; HUMANS; IMMUNITY, NATURAL; INTERPHASE; ISOANTIGENS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MACROPHAGES; T-LYMPHOCYTES; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0033564301     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Clerici, M., L. DePalma, E. Roilides, R. Baker, and G. M. Shearer. 1993. Analysis of T-helper and antigen-presenting functions in cord blood and peripheral blood leukocytes from healthy children of different ages. J. Clin. Invest. 91:2829.
2. Risdaon, G., J. Gaddy, and H. E. Broxmeyer. 1994. Allogeneic responses in human cord blood. Blood Cells 20:566.
3. Soderberg-Naucler, C., K. N. Fish, and J. A. Nelson. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91-119.
4. Britt, W. J., and C. A. Alford. 1996. Cytomegalovirus. In Fields Virology. B. N. Fields, D. M. Knipe, and P. M. Howley, eds. (Lippincott-Raven Publishers, Philadelphia, pp. 2493-2523.
5. Scott, E. J. 1991. Anti-cell antibody in macaques. Nature 353:393.
6. Chan, W. L., A. Rodgers, R. D. Hancock, F. Taffs, P. Kitchin, G. Farrar, and F. Y. Liew. 1992. Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody responses. J. Exp. Med. 176:1203.
7. Langlois, A. J., K. J. Weinhold, T. J. Matthews, M. L. Greenberg, and D. P. Bolognesi. 1992. Detection of anti-human cell antibodies in sera from macaques immunized with whole-inactivated virus. AIDS Res. Hum. Retroviruses 8:1641.
8. Arthus, L. O., J. W. Bess, Jr., R. G. Urban, J. L. Strominger, W. R. Morton, D. L. Mann, L. E. Henderson, and R. E. Benveniste. 1995. Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J. Virol. 69:3117.
9. Chan, W. L., A. Rodgers, C. Grief, N. Almond, S. Ellis, B. Flanagan, P. Silvera, J. Bootman, J. Scott, K. Kent, and R. Bomford. 1995. Immunization with class I human histocompatibility leukocyte antigen can protect macaques against challenge infection with SIVmac-32H. AIDS 9:223.
10. Gardner, M., A. Rosenthal, M. Jennings, J. Yee, L. Antipa, and E. Robinson, Jr. 1995. Passive immunization of rhesus macaques against SIV infection and disease. AIDS Res. Hum. Retroviruses 11:843.
11. Arthur, L. O., J. W. Bess, Jr., R. C. Sowder, II, R. E. Benveniste, D. L. Mann, J. C. Chermann, and L. E. Henderson. 1992. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258: 1935.
12. Tremblay, M. J., J.-F. Fortin, and R. Cantin. 1998. The acquisition of host-encoded proteins by nascent HIV-1. Immunol. Today 19:346.
13. Kiprov, D. D., H. W. Sheppard, and C. V. Hanson. 1994. Alloimmunization to prevent AIDS. Science 263:161.
14. Plummer, F. A., K. Fowke, N. J. D. Nagelkerke, J. N. Simonsen, J. Brayo, and E. Ngugi. 1993. Evidence of resistance to HIV among continuously exposed prostitutes in Nairobi, Kenya [abstract WS-A07-3]. In Program and Abstracts: IX International Conference on AIDS/HIV STD World Congress (Berlin). Welcome Foundation, London.
15. + T-cell-derive factor(s), but not β-chemokines, RANTES, MIP-1α, Acad. Sci. USA 93:15341.
16. Moriuchi, H., M. Moriuchi, J. Arthos, J. Hoxie, and A. S. Fauci. 1997. Promonocytic U937 clones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion with T-tropic HIV-1. J. Virol. 71-9664.
17. + T cells during primary HIV-1 infection. Proc. Natl. Acad. Sci. USA 95:8869.
18. Panteleo, G., and A. S. Fauci. 1995. New concepts in the immunopathogenesis of HIV infection. Annu. Rev. Immunol. 13:487.
19. Connor, R., K. E. Sheridan, C. Ceradini, S. Choe, and N. R. Landau. 1997. Change in coreceptor use correlates with disease progression. J. Exp. Med. 185: 621.
20. Schuitemaker, H., M. Koot, N. A. Kootstra, M. W. Dercksen, R. E. de Goede, R. P. van Steenwijk, J. M. Lange, J. K. Schattenkerk, F. Miedema, and M. Tersmette. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66:1354.
21. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, et al. 1996. Identification of a major coreceptor for primary isolates of HIV-1. Nature 381:661
22. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of seven-transmembrane, G protein-coupled receptor. Science 272-872.
23. Bush, M. P., T.-H. Lee, and J. Heitman. 1992. Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implication for transfusion support of infected patients. Blood 80:2128.
24. Fauci, A. S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature 384:529.
25. Stanley, S. K., M. A. Ostrowski, J. S. Justement, K. Gantt, S. Hedayati, M. Mannix, K. Roche, D. J. Schwartzentruber, C. H. Fox, and A. S. Fauci. 1996. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N. Engl. J. Med. 334-1222.
26. Ostrowski, M. A., S. K. Stanley, J. S. Justement, K. Gantt, D. Goletti, and A. S. Fauci. 1997. Increased in vitro tetanus-induced production of HIV type 1 following in vivo immunization of HIV type 1-infected individuals with tetanus toxoid. AIDS Res. Hum. Retroviruses 13:473.
27. O'Brien, W. A., K. Grovit-Ferbas, A. Namazi, J. Q. Zhao, A. Diagne, K. Idler, J. A. Zack, and I. S. Y. Chen. 1995. Human immunodeficiency virus type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 86:1082.
28. Stapran, S. I., B. L. Hamilton, S. E. Follansbee, T. Elbeik, P. M. Barbosa, R. M. Grant and M. B. Feinberg. 1995. Activation of virus replication after vaccination of HIV-1-infected individuals. J. Exp. Med. 182:1727.
29. Mudido, P.M., D. Georges, D. Dorazio, B. Yen-Lieberman, S. Bae, W. A. O'Brien, J. Spritzler, and M. M. Lederman. 1996. Human immunodeficiency virus type 1 activation after blood transfusion. Transfusion 36:860.
30. Bowden, R. A., R. W. Coombs, B. H. Nikora, C. Bigelow, G. E. Sale, E. D. Thomas, J. D. Meyers, and L. Corey. 1990. Progression of human immumodeficiency virus type-1 infection after allogeneic marrow transplantation. Am. J. Med. 88:49N.
31. French, R. and P. Brocklehurst. 1998. The effect of pregnancy on survival in women infected with HIV: a systematic review of the literature and meta-analysis. Br. J. Obstet. Gynaecol. 105:827.
32. Wang, Y., L. Tao, E. Mitchell, W. M. J. M. Bogers, C. Doyle, C. A. Bravery, L. A. Bergmeier, C. G. Kelly, J. L. Heeney, and T. Lehner. 1998. Generation of CD8 suppressor factor and β chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques. Proc. Natl. Acad. Sci. USA 95:5223.
33. Pinto, L. A., S. Sharpe, D. I. Cohen, and G. M. Shearer. 1998. Alloantigen-stimulated anti-HIV activity. Blood 92:3346.
34. Doms, R.W., and S. Peiper. 1997. Unwelcome guests with master keys: how HIV uses chemokine receptors for cellular entry. Virology 235:179.
35. Moriuchi, H., M. Moriuchi, and A. S. Fauci. 1998. Factors secreted by human T lymphotropic virus type 1 (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells: implications for in vivo coinfection with HTLV-I and HIV-1. J. Exp. Med. 187:1689.
36. + T cells: role of signal transduction. Proc. Natl. Acad. Sci. USA 95:11880.
37. Dolei, A., A. Biolchini, C. Serra, S. Curreli, E. Gomes, and F. Dianzani. 1998. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1α, MIP-1β and RANTES β-chemokines. AIDS 12:183.
38. Moriuchi, M., H. Moriuchi, W. Turner, and A. S. Fauci. 1998. Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1. J. Clin. Invest. 102:1540.